Brian is a globally recognised leader in ageing biology, dedicated to translating scientific research into therapies for age-related diseases. He served as CEO of the Buck Institute for Research on Ageing (2010–2016) and currently leads the Centre for Healthy Longevity at the National University of Singapore, where he is also a Distinguished Professor. His work focuses on advancing human healthspan through cutting-edge research and community-based initiatives. Brian holds honorary appointments at the University of Southern California and the University of Washington and serves as Scientific Director at Affirmative Health. He is Co-Editor-in-Chief of Aging Cell and has held visiting positions at several international institutions, contributing significantly to the global field of ageing research.

Ana is a longevity and precision medicine expert with over 25 years of experience and advanced degrees, including an MD, PhD, and six MScs. She serves as Chief Science Officer at 'LongevityTech.fund' and Chief Medical Officer at 'HealthyLongevity.clinic', and advises multiple biotech and health organisations globally. Recognised as a Forbes Middle East 2024 Healthcare Leader, Ana specialises in translational longevity medicine, precision health, and scalable health solutions. She also lectures in the Master in Longevity programme at the University of Barcelona. A proud mother of six, Ana is passionate about advancing healthy ageing worldwide.

Prof. Eran Segal is a leader in computational biology, specialising in AI-driven personalised medicine using big data from microbiome, genetics, nutrition, and lifestyle studies. He is Department Chair of Computational Biology at MBZUAI and a Professor at the Weizmann Institute of Science. His multidisciplinary lab combines computational and experimental approaches to understand health and disease. With over 230 publications and an H-index of 110, he has earned prestigious awards including the Overton Prize and the Michael Bruno Award.